Mark Kreston

Mark Kreston has extensive work experience in the pharmaceutical and biotech industries. Mark has held senior leadership positions in multiple companies, including AreteiaTx, Knopp Biosciences LLC, Celgene, Johnson & Johnson, and Bristol Myers Squibb.

At AreteiaTx, Mark is currently serving as the SVP & Chief Commercial Officer. Prior to this role, they worked as the Chief Commercial Officer & SVP Business Development at Knopp Biosciences LLC. In this position, they provided executive business leadership and was responsible for enterprise strategy, capitalization strategy, portfolio valuation and commercialization, business development, and investor relations.

Mark also had a notable tenure at Celgene, where they held the position of Corporate VP Global Marketing, Inflammation & Immunology. Mark led the Global Marketing and Global Market Access organizations and played a significant role in brand marketing, market access, pricing, market research, and business development. Additionally, Mark developed global commercialization and life cycle plans for the launch of OTEZLA and contributed to strengthening the pipeline through acquisitions.

Prior to Celgene, Mark worked at Johnson & Johnson, where they held various roles. Mark served as the Worldwide Vice-President Immunology, providing strategic and commercial leadership for a $7.8B franchise. Mark also held the position of Worldwide VP - CNS and managed a marketing department of 17 people. During their tenure at Johnson & Johnson, Mark developed growth strategies aligning R&D with commercialization and played a crucial role in driving commercial success.

Before joining Johnson & Johnson, Mark worked at Bristol Myers Squibb as the Worldwide Vice-President, Immunology. In this role, they developed global commercialization plans for biotech drugs, contributed to sustainable growth initiatives, and established competitive advantage. Mark also served as the President, Consumer Medicines at Bristol Myers Squibb, managing the P&L for a consumer medicines business across North America and Japan.

Mark began their career at Johnson & Johnson as a Product Director, working on notable brands such as Tylenol and Pepcid.

Overall, Mark Kreston has demonstrated a strong track record of executive leadership and strategic management in the pharmaceutical and biotech industries, with a focus on commercialization, business development, and brand marketing in the fields of immunology and neurology.

Mark Kreston completed their Bachelor of Arts (B.A.) degree in International Relations from the University of Pennsylvania between 1979 and 1983. Later, they pursued a Masters in Business Administration (MBA) with a focus on Marketing at the Cornell Johnson Graduate School of Management from 1986 to 1988.